{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:12:42Z","timestamp":1780420362353,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.intimp.2020.106743","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T15:15:40Z","timestamp":1593530140000},"page":"106743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Inhibition of phosphodiesterase IV enzyme improves locomotor and sensory complications of spinal cord injury via altering microglial activity: Introduction of Roflumilast as an alternative therapy"],"prefix":"10.1016","volume":"86","author":[{"given":"Kamyar","family":"Moradi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Golbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farinaz","family":"Haghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khashayar","family":"Afshari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Nikbakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Khavandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Faghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Badripour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Etemadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ashraf-Ganjouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayna","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2020.106743_b0005","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000279335","article-title":"Incidence of spinal cord injury worldwide: a systematic review","volume":"34","author":"Van den Berg","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"16","key":"10.1016\/j.intimp.2020.106743_b0010","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1517\/14656566.9.16.2773","article-title":"New perspectives for the treatment options in spinal cord injury","volume":"9","author":"Sharma","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.intimp.2020.106743_b0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.55782\/ane-2011-1848","article-title":"Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade","volume":"71","author":"Oyinbo","year":"2011","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.intimp.2020.106743_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41393-018-0168-x","article-title":"Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: introduction of an alternative therapy","author":"Afshari","year":"2018","journal-title":"Spinal Cord."},{"issue":"4","key":"10.1016\/j.intimp.2020.106743_b0025","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13179","article-title":"Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury","volume":"173","author":"Faden","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106743_b0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2020.106743_b0035","doi-asserted-by":"crossref","unstructured":"K.A. Jablonski, S.A. Amici, L.M. Webb, D. Ruiz-Rosado Jde, P.G. Popovich, S. Partida-Sanchez, M. Guerau-de-Arellano, Novel markers to delineate murine M1 and M2 macrophages, PloS One 10(12) (2015) e0145342. doi: 10.1371\/journal.pone.0145342.","DOI":"10.1371\/journal.pone.0145342"},{"issue":"6","key":"10.1016\/j.intimp.2020.106743_b0040","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/neu.2010.1575","article-title":"A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes, and tissue damage after spinal cord injury","volume":"28","author":"Bao","year":"2011","journal-title":"J. Neurotrauma"},{"issue":"6","key":"10.1016\/j.intimp.2020.106743_b0045","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/nau.23158","article-title":"Effects of an alpha1A\/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury","volume":"36","author":"Kadekawa","year":"2017","journal-title":"Neurourol. Urodyn."},{"issue":"9","key":"10.1016\/j.intimp.2020.106743_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043634","article-title":"The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury","volume":"7","author":"Schaal","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.intimp.2020.106743_b0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pupt.2010.03.011","article-title":"The preclinical pharmacology of roflumilast\u2013a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease","volume":"23","author":"Hatzelmann","year":"2010","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2020.106743_b0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pharmthera.2004.12.001","article-title":"PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression","volume":"106","author":"Sanz","year":"2005","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2020.106743_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep40144","article-title":"Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment","volume":"7","author":"Gensel","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.intimp.2020.106743_b0070","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2460\/javma.1977.171.09.842","article-title":"Ketamine and xylazine for surgical anesthesia in rats","volume":"171","author":"Van","year":"1977","journal-title":"J. Am. Vet. Med. Assoc."},{"issue":"1","key":"10.1016\/j.intimp.2020.106743_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/neu.1995.12.1","article-title":"A sensitive and reliable locomotor rating scale for open field testing in rats","volume":"12","author":"Basso","year":"1995","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.intimp.2020.106743_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-10-26","article-title":"A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments","volume":"10","author":"Bonin","year":"2014","journal-title":"Mol. Pain"},{"issue":"7","key":"10.1016\/j.intimp.2020.106743_b0085","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"2","key":"10.1016\/j.intimp.2020.106743_b0090","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awp322","article-title":"Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment","volume":"133","author":"Beck","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2020.106743_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.12.045","article-title":"Macrophage activation and its role in repair and pathology after spinal cord injury","volume":"1619","author":"Gensel","year":"2015","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.intimp.2020.106743_b0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.wco.0000169752.54191.97","article-title":"Role of inflammation in neurodegenerative diseases","volume":"18","author":"Minghetti","year":"2005","journal-title":"Curr. Opin. Neurol."},{"issue":"43","key":"10.1016\/j.intimp.2020.106743_b0105","doi-asserted-by":"crossref","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","article-title":"Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord","volume":"29","author":"Kigerl","year":"2009","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.intimp.2020.106743_b0110","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1089\/neu.2011.2109","article-title":"Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury","volume":"29","author":"Nakajima","year":"2012","journal-title":"J. Neurotrauma"},{"issue":"1","key":"10.1016\/j.intimp.2020.106743_b0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-2094-9-40","article-title":"Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice","volume":"9","author":"Guerrero","year":"2012","journal-title":"J. Neuroinflammat."},{"issue":"9","key":"10.1016\/j.intimp.2020.106743_b0120","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2020.106743_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2014.11.007","article-title":"Adoptive transfer of M2 macrophages promotes locomotor recovery in adult rats after spinal cord injury","volume":"45","author":"Ma","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.intimp.2020.106743_b0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12974-015-0463-9","article-title":"Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines","volume":"13","author":"Ghosh","year":"2016","journal-title":"J. Neuroinflammat."},{"issue":"23","key":"10.1016\/j.intimp.2020.106743_b0135","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1073\/pnas.0402595101","article-title":"The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery","volume":"101","author":"Nikulina","year":"2004","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.intimp.2020.106743_b0140","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020602","article-title":"Central nervous system regenerative failure: role of oligodendrocytes, astrocytes, and microglia","volume":"7","author":"Silver","year":"2015","journal-title":"Cold Spring Harbor. Perspect. Biol."},{"issue":"7598","key":"10.1016\/j.intimp.2020.106743_b0145","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature17623","article-title":"Astrocyte scar formation aids central nervous system axon regeneration","volume":"532","author":"Anderson","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2020.106743_b0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.expneurol.2013.12.024","article-title":"Functional regeneration beyond the glial scar","volume":"253","author":"Cregg","year":"2014","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106743_b0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.expneurol.2007.06.020","article-title":"The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury","volume":"209","author":"Hannila","year":"2008","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.intimp.2020.106743_b0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00441-012-1432-6","article-title":"The role of Nogo-A in axonal plasticity, regrowth and repair","volume":"349","author":"Pernet","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.intimp.2020.106743_b0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2013.09.004","article-title":"Cyclic AMP promotes axon regeneration, lesion repair and neuronal survival in lampreys after spinal cord injury","volume":"250","author":"Lau","year":"2013","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106743_b0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.resp.2009.06.005","article-title":"The crossed phrenic phenomenon and recovery of function following spinal cord injury","volume":"169","author":"Goshgarian","year":"2009","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"9","key":"10.1016\/j.intimp.2020.106743_b0175","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1523\/JNEUROSCI.5464-09.2010","article-title":"Calcium and cyclic AMP promote axonal regeneration in Caenorhabditis elegans and require DLK-1 kinase","volume":"30","author":"Ghosh-Roy","year":"2010","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.intimp.2020.106743_b0180","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nm1056","article-title":"cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury","volume":"10","author":"Pearse","year":"2004","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2020.106743_b0185","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/cne.22057","article-title":"Axon regeneration in the absence of growth cones: acceleration by cyclic AMP","volume":"515","author":"Jin","year":"2009","journal-title":"J. Comparat. Neurol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106743_b0190","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0896-6273(02)00702-X","article-title":"Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation","volume":"34","author":"Neumann","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2020.106743_b0195","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbr.2012.12.056","article-title":"Rolipram promotes functional recovery after contusive thoracic spinal cord injury in rats","volume":"243","author":"Costa","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.intimp.2020.106743_b0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s13311-011-0032-6","article-title":"Emerging concepts in myeloid cell biology after spinal cord injury","volume":"8","author":"Hawthorne","year":"2011","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.intimp.2020.106743_b0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ejp.905","article-title":"Neuropathic pain prevalence following spinal cord injury: A systematic review and meta-analysis","volume":"21","author":"Burke","year":"2017","journal-title":"Europ. J. Pain (London, England)"},{"issue":"16","key":"10.1016\/j.intimp.2020.106743_b0210","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1523\/JNEUROSCI.0003-06.2006","article-title":"Activated microglia contribute to the maintenance of chronic pain after spinal cord injury","volume":"26","author":"Hains","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2020.106743_b0215","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.expneurol.2014.02.001","article-title":"Neuroinflammatory contributions to pain after SCI: roles for central glial mechanisms and nociceptor-mediated host defense","volume":"258","author":"Walters","year":"2014","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106743_b0220","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/j.pain.0000000000000783","article-title":"Neuropathic pain after spinal cord injury: the impact of sensorimotor activity","volume":"158","author":"Nees","year":"2017","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.intimp.2020.106743_b0225","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0166-2236(00)01854-3","article-title":"Glial activation: a driving force for pathological pain","volume":"24","author":"Watkins","year":"2001","journal-title":"Trends Neurosci."},{"issue":"9","key":"10.1016\/j.intimp.2020.106743_b0230","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/j.1460-9568.2004.03709.x","article-title":"Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats","volume":"20","author":"Milligan","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.intimp.2020.106743_b0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/(SICI)1098-1136(199805)23:1<75::AID-GLIA7>3.0.CO;2-3","article-title":"Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior","volume":"23","author":"Coyle","year":"1998","journal-title":"Glia"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2020.106743_b0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0006-8993(99)01186-5","article-title":"Microglial reactions after subcutaneous formalin injection into the rat hind paw","volume":"825","author":"Fu","year":"1999","journal-title":"Brain Res."},{"issue":"10","key":"10.1016\/j.intimp.2020.106743_b0245","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1523\/JNEUROSCI.23-10-04017.2003","article-title":"p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain","volume":"23","author":"Jin","year":"2003","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2020.106743_b0250","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/glia.20176","article-title":"Cell proliferation and replacement following contusive spinal cord injury","volume":"50","author":"Zai","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.intimp.2020.106743_b0255","first-page":"208","article-title":"Transcriptional profiling of spinal cord injury-induced central neuropathic pain: the role of activated astrocytes","volume":"94","author":"Nesic-Taylor","year":"2005","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.intimp.2020.106743_b0260","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2174\/1381612053507864","article-title":"From discovery to clinical trials: treatment strategies for central neuropathic pain after spinal cord injury","volume":"11","author":"Hulsebosch","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.intimp.2020.106743_b0265","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/j.1460-9568.2005.04451.x","article-title":"Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia","volume":"22","author":"Hua","year":"2005","journal-title":"Eur. J. Neurosci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920307621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920307621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:50:02Z","timestamp":1769028602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920307621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":53,"alternative-id":["S1567576920307621"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106743","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of phosphodiesterase IV enzyme improves locomotor and sensory complications of spinal cord injury via altering microglial activity: Introduction of Roflumilast as an alternative therapy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106743","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106743"}}